Evidence map›Paper›PMID 24211138›Full record

ArticleChemistry & biology2013

Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease.

Junmei Wan, Jeffrey N Savas, Amy F Roth, Shaun S Sanders, Roshni R Singaraja, Michael R Hayden, John R Yates, Nicholas G Davis

Abstract read
In one paragraph

Article in Chemistry & biology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 81 citations in OpenAlex.

  1. Article
  2. Review
  3. Quantification of Protein Palmitoylation by Cysteine-SILAC.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  4. Proteome-wide identification of palmitoylated proteins in mouse testis.Reproductive sciences (Thousand Oaks, Calif.) · 2022
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Glutamine Synthetase as a Therapeutic Target for Cancer Treatment.International journal of molecular sciences · 2021
    Review
  11. Regulation of Dynamic Protein S-Acylation.Frontiers in molecular biosciences · 2021
    Review
  12. Article
  13. Proteome-Scale Analysis of ProteinJournal of proteome research · 2021
    Review
  14. Article
  15. Article
  16. Altered Regulation of Striatal NeuronalFrontiers in synaptic neuroscience · 2019
    Article
  17. Article
  18. Review
  19. Article
  20. Insights Into ProteinFrontiers in molecular neuroscience · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Junmei WanDepartment of Pharmacology, Wayne State University, Detroit, MI 48201, USA.
Jeffrey N Savas
Amy F Roth
Shaun S Sanders
Roshni R Singaraja
Michael R Hayden
John R Yates
Nicholas G Davis
University of British Columbia · CAWayne State University · USScripps Research Institute · US

Funding

TrainingP41GM103533 · NIGMS · UNIVERSITY OF WASHINGTON · PI MACCOSS, MICHAEL · 2012 to 2021
$20.7M
Quantitative Proteome Analysis of Brain DevelopmentR01MH067880 · NIMH · SCRIPPS RESEARCH INSTITUTE, THE · PI YATES III, JOHN R · 2003 to 2017
$7.1M
Protein Palmitoylation in Yeast and MammalsR01GM065525 · NIGMS · WAYNE STATE UNIVERSITY · PI DAVIS, NICHOLAS G · 2002 to 2010
$2.1M
Quantitative Proteomic Approach to Identify the Mechanism of Alzheimer's DiseaseF32AG039127 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI SAVAS, JEFFREY NICHOLAS · 2011 to 2014
$117k
CIHR GPG-102165NIA NIH HHS F32 AG039127NIA NIH HHS F32-AG039127NIGMS NIH HHS P41 GM103533NIGMS NIH HHS P41-GM103533NIGMS NIH HHS R01 GM065525NIGMS NIH HHS R01GM65525NIMH NIH HHS R01 MH067880NIMH NIH HHS R01MH067880
6 · The paper itself

Abstract

Protein palmitoylation, a reversible lipid modification of proteins, is widely used in the nervous system, with dysregulated palmitoylation being implicated in a variety of neurological disorders. Described below is ABE/SILAM, a proteomic strategy that couples acyl-biotinyl exchange (ABE) purification of palmitoyl-proteins to whole animal stable isotope labeling (SILAM) to provide an accurate tracking of palmitoylation change within rodent disease models. As a first application, we have used ABE/SILAM to look at Huntington's disease (HD), profiling palmitoylation change in two HD-relevant mouse mutants: the transgenic HD model mouse YAC128 and the hypomorphic Hip14-gt mouse, which has sharply reduced expression for HIP14 (Zdhhc17), a palmitoyl-transferase implicated in the HD disease process. Rather than mapping to the degenerating neurons themselves, the biggest disease changes instead map to astrocytes and oligodendrocytes (i.e., the supporting glial cells).

Indexed as

Disease Models, AnimalAcyltransferasesAnimalsBrainHuntington DiseaseMiceMice, Inbred C57BLMice, TransgenicNeurogliaPalmitic AcidAcyltransferasesPalmitic AcidZdhhc17 protein, mouse

Identifiers

PMID24211138
PMCPMC3880188
OpenAlexW2089178885

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.